CN110746362A - 依拉戈利酸硫酸盐的晶型及其制备和应用 - Google Patents
依拉戈利酸硫酸盐的晶型及其制备和应用 Download PDFInfo
- Publication number
- CN110746362A CN110746362A CN201911088757.XA CN201911088757A CN110746362A CN 110746362 A CN110746362 A CN 110746362A CN 201911088757 A CN201911088757 A CN 201911088757A CN 110746362 A CN110746362 A CN 110746362A
- Authority
- CN
- China
- Prior art keywords
- degrees
- azt
- crystalline form
- crystal form
- form azt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Description
时间(min) | 流动相A(%) | 流动相B(%) |
0 | 20 | 80 |
20 | 50 | 50 |
30 | 70 | 30 |
50 | 70 | 30 |
51 | 20 | 80 |
60 | 20 | 80 |
Claims (10)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911088757.XA CN110746362A (zh) | 2019-11-08 | 2019-11-08 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
PCT/CN2020/121250 WO2021088616A1 (zh) | 2019-11-08 | 2020-10-15 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911088757.XA CN110746362A (zh) | 2019-11-08 | 2019-11-08 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110746362A true CN110746362A (zh) | 2020-02-04 |
Family
ID=69282730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911088757.XA Pending CN110746362A (zh) | 2019-11-08 | 2019-11-08 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN110746362A (zh) |
WO (1) | WO2021088616A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110372609A (zh) * | 2019-07-25 | 2019-10-25 | 奥锐特药业股份有限公司 | 一种噁拉戈利钠盐的纯化方法 |
WO2021088616A1 (zh) * | 2019-11-08 | 2021-05-14 | 上海迪赛诺化学制药有限公司 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
CN114835649A (zh) * | 2021-02-01 | 2022-08-02 | 上海漠澳浩医药科技有限公司 | 噁拉戈利盐、晶体及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017221144A1 (en) * | 2016-06-20 | 2017-12-28 | Dr. Reddy's Laboratories Limited | Process for the preparation of elagolix sodium and its polymorph |
EP3388421A1 (en) * | 2017-04-13 | 2018-10-17 | Sandoz AG | Acid addition salts of an orally available gonadotropin-releasing hormone receptor antagonist |
WO2018224063A2 (en) * | 2017-06-08 | 2018-12-13 | Zentiva, K.S. | Solid forms of elagolix |
CN109651171A (zh) * | 2019-01-13 | 2019-04-19 | 苏州鹏旭医药科技有限公司 | 依拉戈利及其钠盐的中间体及其盐的制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3572406A1 (en) * | 2018-10-17 | 2019-11-27 | Sandoz Ag | Acid addition salt of elagolix and related compounds |
CN110746362A (zh) * | 2019-11-08 | 2020-02-04 | 安礼特(上海)医药科技有限公司 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
-
2019
- 2019-11-08 CN CN201911088757.XA patent/CN110746362A/zh active Pending
-
2020
- 2020-10-15 WO PCT/CN2020/121250 patent/WO2021088616A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017221144A1 (en) * | 2016-06-20 | 2017-12-28 | Dr. Reddy's Laboratories Limited | Process for the preparation of elagolix sodium and its polymorph |
EP3388421A1 (en) * | 2017-04-13 | 2018-10-17 | Sandoz AG | Acid addition salts of an orally available gonadotropin-releasing hormone receptor antagonist |
WO2018224063A2 (en) * | 2017-06-08 | 2018-12-13 | Zentiva, K.S. | Solid forms of elagolix |
CN109651171A (zh) * | 2019-01-13 | 2019-04-19 | 苏州鹏旭医药科技有限公司 | 依拉戈利及其钠盐的中间体及其盐的制备方法和应用 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110372609A (zh) * | 2019-07-25 | 2019-10-25 | 奥锐特药业股份有限公司 | 一种噁拉戈利钠盐的纯化方法 |
WO2021088616A1 (zh) * | 2019-11-08 | 2021-05-14 | 上海迪赛诺化学制药有限公司 | 依拉戈利酸硫酸盐的晶型及其制备和应用 |
CN114835649A (zh) * | 2021-02-01 | 2022-08-02 | 上海漠澳浩医药科技有限公司 | 噁拉戈利盐、晶体及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2021088616A1 (zh) | 2021-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110746362A (zh) | 依拉戈利酸硫酸盐的晶型及其制备和应用 | |
RU2615509C2 (ru) | Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота | |
US20090298947A1 (en) | Polymorphic and amorphous forms of lacosamide and amorphous compositions | |
WO2013052157A1 (en) | Crystalline forms of afatinib di-maleate | |
US9221815B2 (en) | Solid state form of vemurafenib choline salt | |
US20060094757A1 (en) | Substantially pure cilostazol and processes for making same | |
WO2016016766A2 (en) | A process for the preparation of isavuconazonium or its salt thereof | |
CN111072572B (zh) | Elagolix关键中间体的硫酸氢盐的晶型及其制备和应用 | |
US20100099897A1 (en) | Stable anhydrous crystalline docetaxel and method for the preparation thereof | |
EP2855499A1 (en) | Solid state forms of fidaxomycin and processes for preparation thereof | |
EP2311794B1 (en) | Polymorphs of bromfenac sodium and methods for preparing bromfenec sodium polymorphs | |
WO2004062571A2 (en) | Substantially pure cilostazol and processes for making same | |
WO2012071425A1 (en) | Solid state forms of sorafenib besylate, and processes for preparations thereof | |
KR20150096625A (ko) | 보르테조밉(Bortezomib)의 신규한 결정형 및 그의 제조방법 | |
US10301344B2 (en) | L-proline complex of sodium-glucose cotransporter 2 inhibitor, monohydrate and crystal form thereof | |
US20120220655A1 (en) | Crystalline forms of fesoterodine fumarate and fesoterodine base | |
CN110869382B (zh) | 甾体类衍生物fxr激动剂的结晶或无定型物、其制备方法和用途 | |
EA017521B1 (ru) | Комплексное соединение платины и его применение | |
WO2011001383A1 (en) | Crystalline form of fosamprenavir calcium | |
JP2015007000A (ja) | モンテルカスト遊離酸の結晶を製造する方法 | |
CN111094313B (zh) | 盐酸伊达比星一水合物的晶型 | |
CN109988072B (zh) | 一种2’-氧基二乙胺的合成方法及其产品 | |
CN111566112B (zh) | 埃格列净的晶型及其制备方法 | |
CN105837634B (zh) | 一种泰地唑胺磷酸酯结晶体及其制备方法 | |
JP2022074008A (ja) | トレプロスチニル一水和物結晶およびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20201021 Address after: 201302 room 2, building 456, 338 Xin Hin Road, old town, Shanghai, Pudong New Area Applicant after: SHANGHAI DESANO CHEMICAL PHARMACEUTICAL Co.,Ltd. Applicant after: ARIZEST (SHANGHAI) PHARMATECH Co.,Ltd. Applicant after: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. Address before: 201203 Shanghai Pudong New Area China (Shanghai) Free Trade Pilot Area Zhangheng Road 1999 Building 3 Applicant before: ARIZEST (SHANGHAI) PHARMATECH Co.,Ltd. Applicant before: JIANGSU ACEBRIGHT PHARMACEUTICALS Co.,Ltd. Applicant before: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20221101 Address after: Room 338, Building 2, 456 Liangxin Road, Laogang Town, Pudong New Area, Shanghai, 2013 Applicant after: SHANGHAI DESANO CHEMICAL PHARMACEUTICAL Co.,Ltd. Address before: Room 338, Building 2, 456 Liangxin Road, Laogang Town, Pudong New Area, Shanghai, 2013 Applicant before: SHANGHAI DESANO CHEMICAL PHARMACEUTICAL Co.,Ltd. Applicant before: ARIZEST (SHANGHAI) PHARMATECH Co.,Ltd. Applicant before: SHANGHAI ACEBRIGHT PHARMACEUTICALS GROUP Co.,Ltd. |
|
TA01 | Transfer of patent application right |